BioNTech SE (BNTX) Long-Term Deferred Tax (2020 - 2025)

BioNTech SE has disclosed Long-Term Deferred Tax across 6 years of filings, most recently posting $15.7 million for Q4 2025.

• Long-Term Deferred Tax for Q4 2025 came in at $15.7 million, down 82.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.7 million (down 82.0% YoY), and the FY2025 annual result was $15.3 million, down 82.53% from the prior year.
• Long-Term Deferred Tax came in at $15.7 million for Q4 2025 at BioNTech SE, down from $20.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $346.5 million in Q3 2022 to a low of $15.7 million in Q4 2025.
• The 5-year median for Long-Term Deferred Tax is $99.6 million (2024), against an average of $146.7 million.
• Across the five-year window, Long-Term Deferred Tax decreased 0.19% in 2024 and plunged 82.0% in 2025, its largest moves.
• BioNTech SE's Long-Term Deferred Tax stood at $170.9 million in 2021, then soared by 37.05% to $234.2 million in 2022, then slumped by 62.66% to $87.5 million in 2023, then slipped by 0.19% to $87.3 million in 2024, then slumped by 82.0% to $15.7 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $15.7 million (Q4 2025), $20.7 million (Q3 2025), and $88.1 million (Q2 2025), per Business Quant data.